Pancreatic Cancer Research

ResearcherUniversity of MichiganNo recent work listed

Isaac R. Francis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1953-7740; OpenAlex author ID A5052209029. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
32
Papers, trials and grants by year

2012: 2 papers · 2013: 5 papers · 2014: 2 papers · 2015: none · 2016: none · 2017: 1 paper

Papers 10

  1. Value of pelvis CT during follow-up of patients with pancreatic adenocarcinoma. Last author DOI 10.1007/s00261-016-0869-6↗
  2. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic associatio… First author DOI 10.1053/j.gastro.2013.11.004↗
  3. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Associatio… First author DOI 10.1148/radiol.13131184↗
  4. A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Co-author DOI 10.1002/cncr.28117↗
  5. Prognostic significance of carbohydrate antigen 19-9 in unresectable locally advanced pancreatic cancer treated with dose-escalated intensity modulated radiati… Co-author DOI 10.1016/j.ijrobp.2012.11.020↗
  6. Staging of pancreatic cancer: role of imaging. Last author DOI 10.1053/j.ro.2013.03.005↗
  7. Mimics of pancreatic ductal adenocarcinoma. Last author DOI 10.1102/1470-7330.2013.9012↗
  8. Pancreatic ductal adenocarcinoma staging. First author DOI 10.1102/1470-7330.2013.9020↗
  9. Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer. Co-author DOI 10.1016/j.ijrobp.2011.08.022↗
  10. A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pa… Co-author DOI 10.1016/j.ijrobp.2012.02.051↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mahmoud M. Al-Hawary · 5 shared papers, 2013–2014 · strength 0.25
  2. Diane M. Simeone · 4 shared papers, 2012–2014 · strength 0.13
  3. Theodore Steven Lawrence · 4 shared papers, 2012–2013 · strength 0.12
  4. Edgar Ben‐Josef · 4 shared papers, 2012–2013 · strength 0.12
  5. Mark M. Zalupski · 4 shared papers, 2012–2013 · strength 0.12
  6. Ravi Kiran Kaza · 2 shared papers, 2013 · strength 0.10
  7. Koenraad J. Mortelé · 2 shared papers, 2014 · strength 0.07
  8. Eric Peter Tamm · 2 shared papers, 2014 · strength 0.07
  9. Nipun B. Merchant · 2 shared papers, 2014 · strength 0.07
  10. Suresh T. Chari · 2 shared papers, 2014 · strength 0.07
  11. Frank H. Miller · 2 shared papers, 2014 · strength 0.07
  12. Dushyant V. Sahani · 2 shared papers, 2014 · strength 0.07
  13. Elliot K. Fishman · 2 shared papers, 2014 · strength 0.07
  14. Alec J. Megibow · 2 shared papers, 2014 · strength 0.07
  15. Jason J. Bailey · 1 shared paper, 2017 · strength 0.07
  16. Vaibhav Sahai · 1 shared paper, 2017 · strength 0.07
  17. William Leslie · 2 shared papers, 2012–2013 · strength 0.06
  18. Ross Allen Abrams · 2 shared papers, 2012–2013 · strength 0.06
  19. Gazala Naaz Khan · 2 shared papers, 2012–2013 · strength 0.06
  20. Jeffrey M. Vainshtein · 1 shared paper, 2013 · strength 0.04
  21. Klaudia Urbaniak Hunter · 1 shared paper, 2012 · strength 0.03
  22. James Don Murphy · 1 shared paper, 2012 · strength 0.03
  23. Edward Jae-Hoon Kim · 1 shared paper, 2013 · strength 0.03
  24. Joseph M. Herman · 1 shared paper, 2013 · strength 0.03
  25. Mark Bloomston · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.